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Abstract
Background: Increasing energy expenditure at the cellular level offers an attractive option to limit adiposity and improve
whole body energy balance. In vivo and in vitro observations have correlated mitochondrial uncoupling protein-1 (UCP1)
expression with reduced white adipose tissue triglyceride (TG) content. The metabolic basis for this correlation remains
unclear.
Methodology/Principal Findings: This study tested the hypothesis that mitochondrial uncoupling requires the cell to
compensate for the decreased oxidation phosphorylation efficiency by up-regulating lactate production, thus redirecting
carbon flux away from TG synthesis. Metabolic flux analysis was used to characterize the effects of non-lethal, long-term
mitochondrial uncoupling (up to 18 days) on the pathways of intermediary metabolism in differentiating 3T3-L1 adipocytes.
Uncoupling was induced by forced expression of UCP1 and chemical (FCCP) treatment. Chemical uncoupling significantly
decreased TG content by ca. 35%. A reduction in the ATP level suggested diminished oxidative phosphorylation efficiency in
the uncoupled adipocytes. Flux analysis estimated significant up-regulation of glycolysis and down-regulation of fatty acid
synthesis, with chemical uncoupling exerting quantitatively larger effects.
Conclusions/Significance: The results of this study support our hypothesis regarding uncoupling-induced redirection of
carbon flux into glycolysis and lactate production, and suggest mitochondrial proton translocation as a potential target for
controlling adipocyte lipid metabolism.
Citation: Si Y, Shi H, Lee K (2009) Metabolic Flux Analysis of Mitochondrial Uncoupling in 3T3-L1 Adipocytes. PLoS ONE 4(9): e7000. doi:10.1371/
journal.pone.0007000
Editor: Jean Peccoud, Virginia Tech, United States of America
Received March 19, 2009; Accepted July 20, 2009; Published September 10, 2009
Copyright:  2009 Si et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was in part supported by a National Institutes of Health grant (DK67228-01) and National Science Foundation grant (0651359) to KL. The
funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: kyongbum.lee@tufts.edu
¤ Current address: Obesity Research Center, School of Medicine, Boston University, Boston, Massachusetts, United States of America
Introduction
At the whole body level, obesity results from a chronically
positive energy balance. Drug therapies have generally been aimed
at reducing energy intake. For example, sibutramine’s mode of
action is to suppress appetite [1], while orlistat’s mode of action is
to block nutrient absorption [2]. Unfortunately, neither drug has
shown significant long-term efficacy. An alternative approach for
improving bodily energy balance is to increase expenditure at the
cellular level. The white adipocyte is a logical target, because its
hypertrophic growth directly contributes to obesity [3].
In adipocytes, ATP production occurs mainly in the mitochon-
dria through oxidative phosphorylation. The efficiency of
oxidative phosphorylation depends on tight coupling between
substrate metabolism, electron transport and proton pumping
across the inner mitochondrial membrane. In response to cold
stress, brown (but not white) adipocytes can loosen this coupling by
inducing a mitochondrial proton channel protein (uncoupling
protein-1 or UCP1). Situated across the inner membrane of the
mitochondria, UCP1 facilitates the reentry of the protons into the
mitochondrial matrix. This reentry bypasses ATP synthase,
dissipating the chemical potential across the mitochondrial
membrane as heat [4]. The impact of UCP1 induction on energy
expenditure in white adipocytes has been studied both in vivo [5]
and in vitro [5,6,7,8]. In these studies, increased UCP1 expression
significantly correlated with a reduction in adipocyte or adipose
tissue triglyceride (TG) content.
Recently,weexaminedthemetabolicbasisofTGreductionusing
a 3T3-L1 cell line that stably expresses UCP1 under the regulation
of a tetracycline-responsive promoter [9]. Our results agreed with
previous findings that expressing UCP1 in white adipocyte reduces
TG accumulation. However, our data did not support an up-
regulation of substrate oxidation. Rather, metabolic rate measure-
ments pointed to a down-regulation of lipid synthesis. Based on this
previous work, we hypothesized that sustained mitochondrial
uncoupling requires the cell to compensate for the decreased
oxidation phosphorylation efficiency by up-regulating glycolysis,
resulting in a redirection of carbon flux away from lipid synthesis.
In this study,we addressedthishypothesis byanalyzing theeffects
of mitochondrial uncoupling on the pathways of intermediary
metabolism in white adipocytes. Mitochondrial uncoupling was
established in two ways. In addition to forced UCP1 expression, we
also applied a chemical uncoupler, carbonyl cyanide p-trifluro-
methoxyphenyl-hydrazone (FCCP).Similar to UCP1, FCCP acts as
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membraneof the mitochondria [10]. Previous studies have reported
that short-term FCCP treatment (up to a few hours) acutely
stimulates cellular respiration [11,12,13], reduces mitochondrial
membrane potential [14], and lowers both fatty acid synthesis [15]
and lipolysis [16]. A very recent gene expression analysis performed
on 3T3-L1 adipocytes showed that long-term FCCP treatment (up
to 6 days) lowered the transcript levels of several enzymes involved
in fatty acid synthesis [17]. Here, we used a metabolic flux analysis
model [18] to compare chemical and protein-mediated uncoupling
at the level of metabolic pathway activity.
Methods
Materials
3T3-L1 preadipocytes were obtained from ATCC (Manassas,
VA). Tissue culture reagents including Dulbecco’s Modified
Eagle’s Medium (DMEM), calf serum (CS), fetal bovine serum
(FBS), human insulin, and penicillin/streptomycin were purchased
from Invitrogen (Carlsbad, CA). Unless otherwise noted, all other
chemicals were purchased from Sigma (St. Louis, MO).
Cell culture and differentiation
3T3-L1 preadipocytes carrying pRevTRE-UCP1 or pRevTRE-
null plasmids were prepared as described previously [9].
Unmodified and stably transfected 3T3-L1 preadipocytes were
plated onto 24-well plates and expanded in preadipocyte growth
medium consisting of DMEM supplemented with CS (10% v/v),
penicillin and streptomycin. Medium was replenished every other
day. Two days post-confluence, the cells were induced to
differentiate using an adipogenic cocktail (1 mg/ml insulin,
0.5 mM isobutylmethylxanthine, and 1 mM dexamethasone)
added to a basal medium (DMEM with 10% FBS and
penicillin/streptomycin). After 48 hrs, the first induction medium
was replaced with a second induction medium consisting of the
basal adipocyte medium supplemented with only insulin. After
another 48 hrs, the second induction medium was replaced with
the basal adipocyte medium. This basal maintenance medium was
replenished every other day during the remainder of the culture
experiments, which lasted 4 to 10 additional days (8 to 14 days
following the addition of the first induction medium).
FCCP treatment
A subset of unmodified 3T3-L1 cells were expanded, induced,
andmaintained inmediacontainingthe chemical uncouplerFCCP.
The drug was stored as a 10 mM stock solution in 95% ethanol at
220uC. Fresh working solutions were prepared at the time of
treatment by diluting the stock solution with growth, induction or
basal maintenance medium as appropriate. A preliminary dose
response experiment showed that a working concentration of 1 mM
did not adversely affect cell growth and viability. Thisconcentration
was used in all FCCP experiments of the present study.
Microscopy
At the indicated time points, cellular morphology was recorded
using phase-contrast microscopy (Nikon-US, Melville, NY). Intra-
cellular lipid droplets were visualized by Oil Red O staining [19].
Real-time RT PCR
Total RNA was isolated using the RNeasy Mini Kit from
QIAGEN(Valencia,CA).Reverse transcriptionwasperformedona
PTC-100 Programmable Thermal Controller (MJ Research,
Waltham, MA) using the High-Capacity cDNA Archive Kit
(Applied Biosystems, Foster City, CA) with random primers. The
peroxisome proliferator-activated receptor-c (PPAR-c) and glycerol-
3-phosphate dehydrogenase (GPDH) mRNA and 18S rRNA levels
weredeterminedusingtheTaqManGeneExpressionassay(Applied
Biosystems, Foster City, CA). All gene expression data were
normalized to the 18S rRNA contents in corresponding samples.
Oxygen uptake
Dissolved oxygen in the culture medium was measured using a
needle-type fiber-optic micro-sensor (MicroxTX3, PreSens
GmbH, Regensburg, Germany). Measurement details, including
experimental setup (Figure S1), are described in Supplementary
Materials S1. The concentration data were related to the oxygen
uptake rate (OUR) using a diffusion-reaction model. The
measured OUR was used for relative comparisons between the
treatment groups and not used for MFA in order to independently
evaluate the calculated OUR.
Metabolite assays
Metabolite measurements were performed both on cell lysates
and spent medium samples as described previously [18]. Cells
were lysed in situ with a 0.1% SDS buffer and sonicated.
Immediately after collection, the spent medium samples were
cleaned of cell debris by a brief centrifugation step. Free glycerol,
TG and FFA were measured using enzymatic assay kits (Sigma).
Glucose and lactate concentrations were measured using the
methods of Trinder [20] and Loomis [21], respectively. Amino
acids were quantified by HPLC (Alliance 2690, Waters, Milford,
MA) using fluorescence-based detection following pre-column
derivatization of primary or secondary amines with 6-aminoqui-
nolyl-N-hydroxysuccinimidyl-carbamate [22]. Cellular ATP was
measured using a luminescence assay kit (Promega, Madison, WI)
that is based on the ATP-dependent activity of luciferase. All
metabolite data were normalized by the corresponding cell sample
DNA content, which was determined with a fluorescence-based
assay using either the Hoechst or PicoGreen dye (Invitrogen). The
PicoGreen dye method was applied to samples used for the ATP
measurements, because the Hoechst dye interfered with the
luminescence assay.
Mitochondrial membrane potential
Mitochondrial membrane potentials in the untreated control and
FCCP-treated cells were determined using tetramethylrhodamine
ethyl ester (TMRE) as a fluorescent probe (Invitrogen). Cells were
incubated with 100 nM TMRE for 30 min at 37uC. After
incubation, the cells were rinsed once with pre-warmed Hank’s
balanced salt solution (HBSS). The culture plates were then
immediately placed in a temperature controlled fluorescence plate
reader (Gemini EX, Molecular Devices, Sunnyvale, CA). TMRE
fluorescence was measured at 549/574 nm excitation/emission.
The membrane potential measurements were performed at various
times during the glucose withdrawal-addition experiment as
indicated in the Results section. The fluorescence reading for each
well was normalized by the corresponding total DNA content.
Stoichiometric model and metabolic flux analysis (MFA)
A stoichiometric network model of adipocyte intermediary
metabolism was constructed as described previously [18]. Table
S1 provides a detailed list of the reactions and their stoichiometry.
Intracellular fluxes were estimated from measurements on
metabolite uptake and output rates (exchange fluxes) by solving
a constrained non-linear optimization problem with stoichiometric
and thermodynamic constraints [23]. Additional details of the flux
calculation are presented in Supplementary Materials S1.
Metabolic Flux in Adipocytes
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Comparisons between two experimental groups were performed
using one-way ANOVA. Group means were deemed to be
statistically significantly different when p,0.05.
Results
Differentiation
The chemical uncoupler (FCCP) was first added to the medium
24 hrs following cell seeding and applied throughout the duration
of the culture experiments. This protocol was designed to mimic
the effects of constitutively expressed uncoupling protein (UCP1).
Differentiation was assessed by measuring the mRNA expression
of PPARc and GPDH on day 8 post-induction [24,25]. Similar to
UCP1 [9], FCCP had no statistically significant effect on the
expression of either gene (Figure 1A).
Lipid storage
The effect of chemical uncoupling on lipid accumulation was
assessed through biochemical assays and morphological analysis.
Continued treatment with FCCP significantly lowered the amount
of accumulated TG by 35% compared to untreated controls
(Figure 1B). Oil Red O staining showed that a smaller fraction of
the FCCP-treated culture (Figure 2A) contained visible lipid
Figure 1. Uncoupling effects on adipogenic conversion. (A) Gene expression levels of GPDH and PPAR-c on day 8 post-induction. (B) Amount
of TG in adipocytes harvested on day 10 post-induction. Data shown are means6SD (n=6). *: significantly different from untreated control (p,0.05).
doi:10.1371/journal.pone.0007000.g001
Figure 2. Morphological comparisons. Oil-Red O stained (top row) and phase contrast (bottom row) images of FCCP treated (left column) and
untreated control cells (right column) on day 8 post-induction.
doi:10.1371/journal.pone.0007000.g002
Metabolic Flux in Adipocytes
PLoS ONE | www.plosone.org 3 September 2009 | Volume 4 | Issue 9 | e7000droplets compared to untreated controls (Figure 2B). Phase
contrast images (Figures 2C and 2D) suggested that even cells
without visible lipid droplets in both treated and untreated control
possessed the round shapes of differentiated 3T3-L1 adipocytes.
Mitochondrial function
As mitochondrial uncouplers, both UCP1 and FCCP should
down-regulate aerobic ATP synthesis and up-regulate oxygen
consumption. Previously, we found that forced expression of
UCP1 did not significantly affect the ATP level when the cells
were incubated in a glucose rich (4.5 g/L) medium (Table S3).
However, incubating the UCP1 expressing cells in a glucose free
medium significantly depressed the ATP level relative to pRev
control cells (Table S3) [9]. Motivated by this finding, the present
study assayed the ATP content of FCCP treated and untreated
control cells during and after a period of glucose starvation. Unlike
UCP1 expression, long-term FCCP treatment significantly
decreased the basal ATP level by ca. 18% even without glucose
starvation (Figure 3A). Withholding glucose for 48 hrs decreased
the ATP levels in the FCCP treated and untreated control cells to
similar extents, as the initial difference in the ATP levels between
the treatment groups remained nearly unchanged. Following the
addition of glucose at the 48 hr time point, the ATP level in the
FCCP treated cells continued to decline significantly until the
72 hr time point (Figure 3B). The ATP decline in the untreated
control cells leveled off statistically, widening the difference in the
ATP levels between the two treatment groups. At the 72 hr time
point (24 hrs after reintroducing the glucose rich medium), the
ATP level in the FCCP treated cells was 30% lower compared to
untreated controls.
In light of the observation that long-term exposure (12 days) to
FCCP lowered the ATP level even in the presence of medium
glucose,we alsoexamined theeffects ofshort-termexposure.After 2
days, the ATP levels in FCCP treated and untreated control cells
were not significantly different when glucose was continuously
present (Figure 3C) or withdrawn and then re-introduced
(Figure 3D). Similar to long-term FCCP exposure, ATP levels
significantly declined in both FCCP treated and control cells during
the glucose starvation. Interestingly, the ATP level in the FCCP
treated cells halted its decline by the 48 hr time point, rather than
Figure 3. Glucose utilization for ATP production. Effect of long-term (A, B) and short-term chemical uncoupling (C, D) on cellular ATP without
(A, C) and with glucose starvation (B, D). In all panels, time zero corresponds to day 10 post-induction. In panels (B) and (D), glucose starvation lasted
from time zero to 48 hrs. Cells were again fed glucose-rich (4.5 g/L) maintenance medium at 48 hrs (arrow). In panels (C) and (D), FCCP was first
introduced at time zero and replenished with the following medium change at 48 hrs. Data shown are means6SD (n=6). *: significantly different
from the untreated control at the corresponding time point (p,0.05). #: significantly different from the 48 hr time point.
doi:10.1371/journal.pone.0007000.g003
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remained unchanged throughout the duration of the 4 day glucose
starvation experiment for both FCCP treated and control cells,
indicating that ATP levels could decline without significant
alterations in the mitochondrial membrane potential (Figure S2).
A further comparison between the two uncoupling modalities
assessed the oxygen uptake rate (OUR), because mitochondrial
proton pumping can drive up to 90% of cellular respiration [26].
Measurements on day 10 post-induction showed that the FCCP
treatment had significantly increased the OUR by 55%
(Figure 4A). Chemical uncoupling also significantly increased the
cellular NAD
+ to NADH ratio by 150% (Figure 4B). The present
study repeated the OUR measurements on the UCP1 expressing
cells and corresponding controls. The OUR values were not
significantly different, consistent with the previous study [9].
Forced expression of UCP1 raised the cofactor ratio, albeit to a
smaller and statistically insignificant extent compared to chemical
uncoupling.
Metabolic flux analysis
We applied MFA to integrate the metabolite measurements and
quantify the broader impact of mitochondrial uncoupling on
adipocyte intermediary metabolism. The flux analysis used
metabolite data collected between days 12 and 14 post-induction,
because the newly differentiated adipocyte were expected to exhibit
the mature phenotype by this time [27]. Figure 5 summarizes the
estimated fluxes through the major pathways. The complete flux
data are shown in Table S2. Overall, there were 18 reactions
significantly affected by both UCP1 expression and FCCP
treatment. These reactions participated in the following pathways:
glycolysis, PPP, lipid metabolism and amino acid metabolism.
UCP1 expression and FCCP treatment increased glucose
uptake by 85 and 95%, respectively. Fluxes through reactions in
glycolysis increased as well. The increases ranged from 60 to 269%
in UCP1 expressing cells and 54 to 129% in FCCP treated cells.
The most substantial flux increase involved lactate dehydrogenase
(LDH). UCP1 expression and FCCP treatment increased lactate
output by 394 and 285%, respectively. Mitochondrial uncoupling
had the opposite effect on the PPP. UCP1 expression and FCCP
treatment significantly decreased the net flux through PPP by 81
and 100%, respectively.
Thefluxestimatesalsopointedtoasignificantdown-regulationof
lipogenesis. Phosphoenolpyruvate carboxykinase (PEPCK) catalyzes
the conversion of cytosolic oxaloacetate (OAA) into phosphoenol-
pyruvate, a keystep in glycerogenesis generatingthe glycerolmoiety
of TG. Uncoupling protein-1 expression and FCCP treatment
decreased the flux through PEPCK by 36 and 78%, respectively.
Uncoupling also reduced the supply of cytosolic acetyl-CoA units
for de novo fatty acid synthesis. UCP1 expression and FCCP
treatment lowered the transport of citrate from the mitochondria
into cytosol and its subsequent cleavage into acetyl-CoA and OAA
by 42 and 78%, respectively. Overall, UCP1 expression and FCCP
treatment depressed the rates of TG formation, accumulation and
lipolysis by 40,52% and 15,80%, respectively.
The changes in amino acid metabolism were relatively small in
magnitude. The largest effects were on the production of proline
and alanine. UCP1 expression and FCCP treatment elevated
alanine production by 70 and 249%, respectively. Proline
formation was nearly zero in the unmodified and untreated
control cells. This flux rose to 1.3 mmol/g-DNA/2-days with the
long-term FCCP treatment. UCP1 expression increased proline
production by 127% compared to the pRev control (transfected
with the empty expression plasmid).
Discussion
A previous study on the metabolic impact of forced UCP1
expression in 3T3-L1 adipocytes indicated a shift of glucose-derived
carbon flux into lactate production instead of lipid synthesis [9]. In
this study, we mimicked the mitochondrial uncoupling effects of
forced UCP1 expression by subjecting cultured 3T3-L1 to mild, but
prolonged FCCP treatment. Similar to UCP1 expression, this
treatment did not affect the transcript levels of PPARc or GPDH,
two markers of adipocyte differentiation. Chemical uncoupling also
reduced the accumulation of TG while increasing glucose uptake
and lactate output. Model calculations revealed generally consistent
metabolic flux changes for both FCCP- and UCP1-mediated
uncoupling, suggesting a common mechanism.
Mitochondrial uncoupling through UCP1 expression and FCCP
treatment both down-regulated de novo fatty acid synthesis (reaction
# 24, Table S2), TG synthesis and storage, and lipolysis (Figure 5).
The uncoupling also reduced the fluxes through several reactions in
other parts of intermediary metabolism that directly or indirectly
couple to fatty acid synthesis. These reactions included steps in the
PPP, PEPCK-catalyzed formation of PEP, and citrate lyase (CL)-
catalyzed formation of cytosolic acetyl-CoA. In adipocytes, the PPP
Figure 4. Oxidative metabolism. Effects of forced UCP1 expression or FCCP treatment on (A) oxygen uptake rate (OUR) and (B) cellular
NAD
+:NADH ratio. Data shown are means6SD (n=6). *: significantly different from pRev or untreated control (p,0.05).
doi:10.1371/journal.pone.0007000.g004
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synthesis [28]. Not surprisingly, the activity of the PPP depends on
the cellular demand for NADPH [29]. This regulatory relationship
suggests that the decrease in the PPP flux also reflects a metabolic
adjustment to the uncoupling. Similarly, the reduced demand for
fatty acid and TG building blocks, respectively, could explain the
reduced flux of acetyl-CoA and PEP.
The estimated flux changes were generally consistent with the
results of a recent study characterizing the impact of chemical
uncoupling on gene expression in mature adipocytes [17].
Expression profiling following short-term (24- or 72-hr) FCCP
treatment found decreased transcript levels of a number of lipogenic
enzymes, including CL, PEPCK, mitochondrial glycerol-3-phos-
phate acyltransferase (GPAT), dihydroxyacetone-phosphate acetyl-
transferase (DHAPAT), fatty acid synthase, HSL and ATGL. In the
same study, measurement of de novo fatty acid synthesis using tritium
labeled acetate estimated a 60% reduction. Model calculations of
the present study estimated similar levels of reduction for long-term
FCCP treatment and UCP1 expression (77 and 41%, respectively).
Another shared effect of UCP1 expression and FCCP treatment
was to substantially elevate net glucose consumption and lactate
production. A possible explanation for this flux adjustment is that
the prolonged uncoupling elicited a metabolic adaptation to
diminished oxidative phosphorylation efficiency. Cultured adipo-
cytes derive ATP primarily from glucose oxidation, because they
have only a limited capacity to mobilize intracellular fat stores
through b-oxidation [30]. Prior studies by our laboratory and
others have shown that neither UCP1 expression nor FCCP
treatment significantly stimulate b-oxidation in 3T3-L1 adipocytes
[9,17]. Conversion of glucose into lactate production via glycolysis
is an alternative route to ATP generation. While the yield of ATP
is less (per mole of glucose), this route does not involve oxidative
Figure 5. Metabolic flux distribution (day 14 post-induction). Top to bottom, values refer to pRev control, UCP1, untreated control and FCCP,
in order. Data shown are means6SD (n=3 for pRev and UCP1; n=6 for untreated control and FCCP). Statistical tests compared UCP1 against pRev
and FCCP against untreated control. Significantly different fluxes are shown in bold blue font (p,0.05). Dashed and dotted lines denote electron and
inter-compartmental transport steps. Mitochondrial metabolites are shown in grey shaded boxes.
doi:10.1371/journal.pone.0007000.g005
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drial uncoupling could induce a greater dependence on glycolytic
ATP generation, especially when there is an abundant supply of
glucose in the medium. In a previous study [9], we found that ATP
levels declined more sharply in the UCP1-expressing adipocytes
when medium glucose was removed. In this study, we found that
FCCP treatment significantly depressed the ATP level even in the
presence of medium glucose, while further increasing the ratio of
lactate production to glucose consumption (Figure 5). Other
studies on inhibitors of mitochondrial metabolism have similarly
noted that glycolytic ATP generation is critical for cell survival
when oxidative phosphorylation is impaired [31,32,33].
Taken together, the results of this study and other prior works
[9,17,34] suggest the following link between mitochondrial
uncoupling and reduction in TG accumulation. Uncoupling
diminishes the efficiency of oxidative phosphorylation, resulting in
a lower yield of ATP. In mammalian cells, biosynthesis pathways
are among the most sensitive to ATP supply [35]. Sustained over
time, the lower ATP yield could signal a down-regulation of
lipogenesis at the level of pathway flux, enzyme synthesis, or both.
Down-regulation of lipogenic flux could involve a change in
cellular redox state. Long-term treatment with FCCP significantly
increased the NAD
+ to NADH ratio. Forced UCP1 expression
elicited a similar trend, although the ratio change was not
statistically significant. The NAD
+ to NADH ratio has been linked
to the activities of several metabolic signaling pathway compo-
nents, including Sirt1, Clock, and CtBP (reviewed in [36]).
Another possible regulatory response is that the lower ATP yield
stimulated the AMP-activated protein kinase (AMPK) pathway. In
adipocytes, AMPK serves as a metabolic master switch [37]. Once
stimulated, the AMPK pathway can reduce ATP utilization by
inactivating enzymes involved in biosynthesis, including lipogen-
esis [38]. Elevated AMPK activity has been found in white adipose
tissue of ap2-UCP1 transfected mice [39], adenovirus-induced
hyperleptinemic rats [6], adiponectin treated rats [40], and rats
after exercise [41]. Interestingly, these animal studies also found
reduced TG levels in the adipose tissue. The AMPK pathway has
been shown to stimulate glucose transport and glycolysis [42],
which could explain the up-regulation of glucose uptake and
lactate output observed in the present study. On the other hand,
AMPK activation by mitochondrial uncoupling was not confirmed
in the present study. Establishing a direct role for this and other
signaling pathways warrants further studies involving knock down
or inhibition experiments.
While the qualitative effects of UCP1 and FCCP were
substantially similar, there were quantitative differences. In general,
the chemical uncoupler generally elicited larger responses. For
example, FCCP treatment increased the OUR by 55%, but UCP1
expression did not result in a significant change. Long-term
treatment with FCCP significantly depressed the cellular ATP level
even in the presence of high glucose (4.5 g/L) in the culture
medium. Forced expression of UCP1 did not significantly depress
the ATP level relative to pRev control unless glucose was removed
from the medium. These differences may reflect an important
distinction between chemical and protein mediated uncoupling.
Uncoupling protein activity is subject to regulation through both
generic and specific endogenous mechanisms. For example, UCP1
levels may be lowered by proteolytic degradation. Alternatively, its
activity maybe modulatedbyfree fattyacids. Ithas been shown that
free fatty acids bind and activate UCP1 in brown adipocytes [43].
Finally, FCCP is a synthetic compound whose metabolic fate in the
adipocyte remains to be clarified. As the adipocyte does not express
high levels of xenobiotic transformation enzymes, it is unlikely that
there are endogenous mechanisms to regulate FCCP activity.
The significant reduction in the basal ATP level (before
starvation) by long-term FCCP treatment might also explain the
relatively minor effect of glucose starvation. Statistical analysis
showed that the ATP level declined further between the 48 and
72 hr time points in the FCCP treated cells compared to the
control cells. While statistically significant, this decline was modest.
One explanation is that the ATP level in the FCCP treated cells
was already nearing a lower limit necessary for maintaining
cellular viability. Interestingly, treating the adipocytes with the
same dose of FCCP (1 mM) for a shorter period of time (up to 4
days) did not adversely affect the ATP level (Figure 3D), suggesting
that different metabolic adjustments may occur depending on the
duration of the uncoupling stress.
In summary, our results suggest that long-term mitochondrial
uncoupling reduces TG accumulation by diverting glucose-derived
carbon flux away from fatty acid synthesis into lactate production.
The molecular mechanisms underlying these observations remain
to be elucidated. In particular, further studies are warranted to
determine the mechanisms of sensing and transducing alterations
in oxidative phosphorylation efficiency. Additional studies are also
needed to explore other mitochondrial membrane components,
for example proton carriers, as prospective targets for controlling
lipid accumulation in adipocytes.
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